B
Brittney A. Klein
Researcher at University of Alberta
Publications - 10
Citations - 71
Brittney A. Klein is an academic researcher from University of Alberta. The author has contributed to research in topics: Troponin I & Fluorine-19 NMR. The author has an hindex of 3, co-authored 10 publications receiving 25 citations.
Papers
More filters
Journal ArticleDOI
Dynamic Nuclear Polarization (DNP) 101: A New Era for Materials
TL;DR: In this paper, the design of new materials requires a deep understanding of the intricacies underpinning their structure-property relationships, and these relationships are modified through synthesis and processing to obtain new materials.
Journal ArticleDOI
Chitosan nanocrystals synthesis via aging and application towards alginate hydrogels for sustainable drug release
Tony Z. Jin,Tracy Liu,Shuaibing Jiang,Davis Kurdyla,Brittney A. Klein,Vladimir K. Michaelis,Edmond Lam,Jianyu Li,Audrey Moores +8 more
TL;DR: Marine biomass waste is a remarkable source of functional molecules and materials that can be used as raw material for renewable energy sources, including coal, gas, oil, and biomass.
Journal ArticleDOI
Reversible Covalent Reaction of Levosimendan with Cardiac Troponin C in Vitro and in Situ.
Brittney A. Klein,Béla Reiz,Ian M. Robertson,Malcolm Irving,Liang Li,Yin-Biao Sun,Brian D. Sykes +6 more
TL;DR: The in vitro mechanism of action of levosimendan is consistent with an allosteric, reversible covalent inhibitor, and the derived kinetic rate constants are used to predict the degree of covalently modified cTnC in vivo under the conditions studied.
Journal ArticleDOI
The Role of Electrostatics in the Mechanism of Cardiac Thin Filament Based Sensitizers
TL;DR: Results show the importance of the positively charged amino group in the negative inotropic effect of W7, and demonstrate that A7 has a much weaker desensitization effect than W7.
Journal ArticleDOI
Thioimidate Bond Formation between Cardiac Troponin C and Nitrile-containing Compounds
TL;DR: The studies reveal the efficacious nature of the malononitrile moiety in targeting cNTnC and its potential in future cardiotonic drug design.